Product category:
Clinical chemistry analysis
News Release from: Perkin Elmer LAS (UK)
Edited by the Laboratorytalk Editorial
Team on 14 February 2005
PerkinElmer acquires Elcos
European designer and manufacturer of custom LED assemblies for biomedical and industrial applications joins the US-based conglomerate
PerkinElmer has announced the acquisition of Elcos, a European designer and manufacturer of custom LED (light emitting diode) assemblies for biomedical and industrial applications The transaction combines Elcos's visible LED technology platform and strong customer and application base with PerkinElmer's global sales, application and support organisation, and will provide significantly greater growth opportunities for the Elcos technology says PerkinElmer
This article was originally published on Laboratorytalk on 19 Apr 2002 at 8.00am (UK)
Related stories
Probing the source of diabetes
Newly developed gene probes increase efficiency and speed of research in studies of type 1 (juvenile) diabetes, detecting the presence of alleles by hybridisation reaction
Manage the entire gene expression process
With microarray labs generating more than one million primary data points daily, this gene expression data management software could speed up actual gene and drug discovery
"Elcos has a successful track record of delivering high performance LEDs to premier OEMs with the majority of their revenue in biomedical instrumentation," said John Roush, president, PerkinElmer Optoelectronics.
"By bringing PerkinElmer and Elcos together we expand our offering of technology for new and existing customers." Specialty LED products are well-suited for a variety of applications, including blood glucose monitoring and patient monitoring systems, as well as a number of industrial applications.
"We have always respected PerkinElmer's unique ability to combine technology expertise, operational excellence and an intimate understanding of customers' needs in order to deliver customised total sales.
"We strongly believe they are the right partner to take Elcos to the next level of success," said Joachim Sieg, founder and CEO of Elcos, who will stay on as a consultant after the acquisition is completed.
Based in Pfaffenhofen, Germany, Elcos had 2004 revenues of US$11.3 million with over 60% coming from health sciences applications, including blood glucose monitoring and pulse oximetry.
PerkinElmer paid US$15 million cash and the potential for earn out payments based on the future performance of the business.
• Perkin Elmer LAS (UK): contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
